Comparison of Ramosetron with Ondansetron for Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Gynecological Surgery

Journal Title: Journal of Medical Science And clinical Research - Year 2015, Vol 3, Issue 9

Abstract

Background: Ramosetron is a new selective 5-hydroxytryptamine type 3 (5HT3) receptor antagonist that reportedly has more potent antiemetic effects compared with other 5HT3 receptor antagonists. The purpose of this study was to evaluate the efficacy of Ramosetron for the prevention of postoperative nausea and vomiting (PONV) with that of Ondansetron in patients undergoing gynecological surgery. Materials and Methods: In this prospective study, 50 healthy patients who were undergoing gynecological operation under general anaesthesia using sevoflurane were enrolled. Patients were divided into two groups: the Ramosetron group (0.3 mg i.v.; n=25) and the Ondansetron group (8 mg i.v.; n=25). The treatments were given 30 minutes before the end of surgery. The incidence of PONV, severity of nausea, and the use of rescue antiemetic requirements during the first 24 h after surgery were evaluated as two groups (0-6 hours and 6-24 hours). Results: The incidence of nausea in the first 6 hours after the surgery in the Ramosetron and Ondansetron groups was 4% & 20% respectively, which was statistically insignificant where as late nausea (6-24 hrs) was 12% and 40% which was statistically significant. 2 patients in the Ondansetron group and none in the Ramosetron group had vomiting during the first 6 hours, which was statistically insignificant, whereas none in the Ramosetron group and 32% of patients in Ondansetron group had vomiting during the late postoperative period of 6-24 hours which was statistically significant. Conclusions: So it was concluded that Ramosetron 0.3 mg i.v. was as effective as Ondansetron 8 mg i.v. in decreasing the incidence of PONV and reducing nausea severity in female patients during the first 6 h after gynecological surgery but Ramosetron was found to be more effective than Ondansetron in prevention of PONV in the 6-24 hours period after the surgery.

Authors and Affiliations

Abhimanyu Singh

Keywords

Related Articles

Effect of Conventional Phototherapy on platelet count in full term and Preterm Neonates with Indirect Hyperbilirubinemia - A Prospective Cohort Study

Jaundice in newborn is quite common and in most of the cases benign in nature. Phototherapy (PT) is one of the most common noninvasive methods of treatment. There are few studies on effect of phototherapy on platelet cou...

Role of Antioxidants and Antioxidant Enzymes in Asthmatic Children

In children, respiratory system is not completely developed .Continuous exposure to environmental factors, pollutants and various infectious agents such as viruses, bacteria etc, makes the system vulnerable to inflammato...

Atypical Granular Cell Tumor with Intranuclear Inclusions: A Case Report

Atypical and malignant granular cell tumors are relatively uncommon constituting 1-2% of all granular cell tumors. We present a case of 57 year old man known to have squamous cell carcinoma of anal canal in 2008, now pre...

Malignant Phyllodes Tumor Mimicking Metaplastic Carcinoma of Breast- A Case Report

In this article we are presenting a case of a 36 year old female with gradually progressive left breast mass who underwent mastectomy surgical procedure and on histopathological examination a diagnosis of malignant phyll...

Download PDF file
  • EP ID EP212345
  • DOI -
  • Views 89
  • Downloads 0

How To Cite

Abhimanyu Singh (2015). Comparison of Ramosetron with Ondansetron for Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Gynecological Surgery. Journal of Medical Science And clinical Research, 3(9), 7429-7436. https://europub.co.uk/articles/-A-212345